Strength of Mind

NeuroStar TMS, or Transcranial Magnetic Stimulation, Therapy is a short outpatient procedure performed right in a psychiatrist’s office. It is a non-invasive (the patient remains awake and alert during the treatment) and non-systemic (not taken orally and does not circulate in the bloodstream) depression treatment for patients who have not benefited from prior antidepressant treatment. TMS Therapy uses highly focused pulsed magnetic fields to stimulate function in targeted brain regions.


The NeuroStar TMS Therapy system generates highly concentrated, magnetic fields, which turn on and off very rapidly. These magnetic fields are the same type and strength as those produced by a magnetic resonance imaging (MRI) machine.

The treatment coil is applied to the head above the left prefrontal cortex. This part of the brain is involved in mood regulation, and is therefore the location where the magnetic fields are focused. These magnetic fields do not directly affect the whole brain. This method allows for a very accurate type of stimulation, minimizing the stimulation of brain tissue not involved in mood. They only reach about 2-3 centimeters into the brain directly beneath the treatment coil. As these magnetic fields pulse they produce very small electrical currents. These small electric currents can cause the neurons (brain cells) to fire or become active and lead to the release of neurotransmitters (the brain’s chemical messengers), helping to relieve the symptoms of depression.

–NeuroStar TMS Therapy, for further reading visit their website here.

Clinical trials have demonstrated the effectiveness of Neurostar TMS Therapy in treating patients who have continued to struggle with Major Depressive Disorder despite treatment with an antidepressant medication or combination of medications.
Patients treated with TMS have experienced significant improvement in depression, anxiety, and physical symptoms (such as appetite changes, aches and pains, sleep disturbances, and lack of energy) associated with depression. Results are definitively known after 4-6 weeks treatment.
TMS has a substantially different and improved safety profile compared to that of any other antidepressant treatment modality currently in use, including pharmacological treatments and device-based treatments (ECT and VNS).
This is in addition to its demonstrated efficacy in MDD (major depressive disorder) patients who failed to achieve satisfactory improvement from previous treatment.

Treatment with TMS causes very few side effects and is generally well tolerated by patients. The most common side effect reported during clinical trials was scalp discomfort—generally mild to moderate and occurring less frequently after the first week of treatment. There is a small risk of <0.1% of a seizure occurring during the treatment course. This risk is no greater than what has been observed with antidepressant medications.

TMS Therapy should not be used in patients with implanted metallic devices or non-removable metallic objects in or around the head. This does not include metallic fillings in teeth. TMS Therapy should not be used in patients with implants controlled by physiological signals. This includes pacemakers and implantable cardioverter defibrillators (ICDs).

Strength of Mind TMS / 8937 S. Garnett Rd Broken Arrow, OK 74012 / (918) 872-9777